Effects of Selective Estrogen Receptor Modulators on Cognitive Aging:  Cognition in the Study of Tamoxifen and Raloxifene (Co-STAR)

Ancillary, NSABP, Co-STAR, Activated 11/01/2001

 

Eligibility Requirements:

 

            Participant on the STAR Trial

 

            At least 60 years old

 

William Jewell, M.D., is the Principal Investigator for this study.  Please contact Brooke Groneman for more information or for patient registration:  (913) 588-4719.